Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zeo ScientifiX's operating cash flow for the twelve months ending Apr 30, 2026 was -$1.25M. For fiscal 2025 it was -$718.00K. The highest annual figure on record is -$8.75K in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | -$718.00K | – |
| FY2024 | Oct 31, 2024 | -$1.45M | – |
| FY2023 | Oct 31, 2023 | -$2.20M | – |
| FY2022 | Oct 31, 2022 | -$3.17M | – |
| FY2021 | Oct 31, 2021 | -$2.68M | – |
| FY2020 | Oct 31, 2020 | -$1.81M | – |
| FY2019 | Oct 31, 2019 | -$565.45K | – |
| FY2018 | Oct 31, 2018 | -$512.00K | – |
| FY2017 | Oct 31, 2017 | -$881.53K | – |
| FY2016 | Oct 31, 2016 | -$548.19K | – |
| FY2015 | Oct 31, 2015 | -$446.52K | – |
| FY2014 | Oct 31, 2014 | -$62.52K | – |
| FY2013 | Oct 31, 2013 | -$29.95K | – |
| FY2012 | Oct 31, 2012 | -$8.75K | – |
| FY2011 | Oct 31, 2011 | -$12.93K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | -$138.00K | – |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | -$471.00K | -824.6% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | -$383.00K | – |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | -$257.00K | – |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | -$143.00K | -164.7% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $65.00K | – |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | -$415.00K | – |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | -$575.00K | – |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $221.00K | – |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | -$464.00K | – |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | -$1.76M | – |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | -$784.30K | – |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | -$63.95K | – |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | -$559.99K | – |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | -$559.43K | – |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | -$502.91K | – |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | -$838.91K | – |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | -$317.21K | – |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | -$379.33K | – |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | -$277.05K | – |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | -$192.89K | – |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | -$117.53K | – |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | -$147.11K | -505.8% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | -$130.34K | – |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | -$171.12K | – |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | -$63.44K | – |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $36.26K | – |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | -$133.50K | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | -$752.38K | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | -$31.91K | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | -$54.70K | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | -$122.64K | – |
| Q2 FY2016CQ1 2016 | Apr 30, 2016 | -$235.70K | – |
| Q1 FY2016CQ4 2015 | Jan 31, 2016 | -$135.15K | – |
| Q4 FY2015CQ3 2015 | Oct 31, 2015 | -$340.81K | – |
| Q3 FY2015CQ2 2015 | Jul 31, 2015 | -$92.34K | – |
See a number that looks wrong?